Cargando…
The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
The Severe Asthma Questionnaire (SAQ) is sensitive to change and clinically significant improvement was detected within 4 weeks of starting biologic therapy. The MCID of the SAQ is 0.5 and of the SAQ-global is 11. https://bit.ly/3poJqcG
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209483/ https://www.ncbi.nlm.nih.gov/pubmed/33632801 http://dx.doi.org/10.1183/13993003.00300-2021 |
| _version_ | 1783709138485772288 |
|---|---|
| author | Masoli, Matthew Lanario, Joseph W. Hyland, Michael E. Menzies-Gow, Andrew Mansur, Adel H. Allen, David Dodd, James W. Hayes, Gemma Valderas, Jose M. Lamb, Sarah E. Jones, Rupert C. |
| author_facet | Masoli, Matthew Lanario, Joseph W. Hyland, Michael E. Menzies-Gow, Andrew Mansur, Adel H. Allen, David Dodd, James W. Hayes, Gemma Valderas, Jose M. Lamb, Sarah E. Jones, Rupert C. |
| author_sort | Masoli, Matthew |
| collection | PubMed |
| description | The Severe Asthma Questionnaire (SAQ) is sensitive to change and clinically significant improvement was detected within 4 weeks of starting biologic therapy. The MCID of the SAQ is 0.5 and of the SAQ-global is 11. https://bit.ly/3poJqcG |
| format | Online Article Text |
| id | pubmed-8209483 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82094832021-06-21 The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference Masoli, Matthew Lanario, Joseph W. Hyland, Michael E. Menzies-Gow, Andrew Mansur, Adel H. Allen, David Dodd, James W. Hayes, Gemma Valderas, Jose M. Lamb, Sarah E. Jones, Rupert C. Eur Respir J Agora The Severe Asthma Questionnaire (SAQ) is sensitive to change and clinically significant improvement was detected within 4 weeks of starting biologic therapy. The MCID of the SAQ is 0.5 and of the SAQ-global is 11. https://bit.ly/3poJqcG European Respiratory Society 2021-06-17 /pmc/articles/PMC8209483/ /pubmed/33632801 http://dx.doi.org/10.1183/13993003.00300-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Agora Masoli, Matthew Lanario, Joseph W. Hyland, Michael E. Menzies-Gow, Andrew Mansur, Adel H. Allen, David Dodd, James W. Hayes, Gemma Valderas, Jose M. Lamb, Sarah E. Jones, Rupert C. The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title | The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title_full | The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title_fullStr | The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title_full_unstemmed | The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title_short | The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference |
| title_sort | severe asthma questionnaire: sensitivity to change and minimal clinically important difference |
| topic | Agora |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209483/ https://www.ncbi.nlm.nih.gov/pubmed/33632801 http://dx.doi.org/10.1183/13993003.00300-2021 |
| work_keys_str_mv | AT masolimatthew thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT lanariojosephw thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT hylandmichaele thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT menziesgowandrew thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT mansuradelh thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT allendavid thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT doddjamesw thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT hayesgemma thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT valderasjosem thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT lambsarahe thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT jonesrupertc thesevereasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT masolimatthew severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT lanariojosephw severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT hylandmichaele severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT menziesgowandrew severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT mansuradelh severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT allendavid severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT doddjamesw severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT hayesgemma severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT valderasjosem severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT lambsarahe severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference AT jonesrupertc severeasthmaquestionnairesensitivitytochangeandminimalclinicallyimportantdifference |